Your browser is no longer supported. Please, upgrade your browser.
We’ve released a new Beta version of our Futures section! Try it now. We look forward to your feedback! ×
Settings
HRT [AMEX]
Arrhythmia Research Technology Inc.
Index- P/E29.52 EPS (ttm)0.23 Insider Own10.70% Shs Outstand2.77M Perf Week-4.37%
Market Cap18.81M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float2.05M Perf Month0.74%
Income0.70M PEG- EPS next Q- Inst Own12.60% Short Float0.61% Perf Quarter-12.27%
Sales24.10M P/S0.78 EPS this Y117.70% Inst Trans11.98% Short Ratio3.46 Perf Half Y15.28%
Book/sh2.60 P/B2.61 EPS next Y- ROA5.70% Target Price- Perf Year38.57%
Cash/sh0.07 P/C94.04 EPS next 5Y- ROE12.90% 52W Range4.60 - 8.00 Perf YTD-11.82%
Dividend- P/FCF94.04 EPS past 5Y10.40% ROI7.80% 52W High-15.13% Beta1.19
Dividend %- Quick Ratio0.80 Sales past 5Y2.70% Gross Margin19.50% 52W Low47.61% ATR0.33
Employees98 Current Ratio1.20 Sales Q/Q-6.60% Oper. Margin3.70% RSI (14)38.26 Volatility3.33% 4.74%
OptionableNo Debt/Eq0.61 EPS Q/Q133.30% Profit Margin3.70% Rel Volume3.14 Prev Close7.00
ShortableYes LT Debt/Eq0.25 EarningsMar 20 Payout0.00% Avg Volume3.61K Price6.79
Recom- SMA20-3.43% SMA50-7.17% SMA200-4.18% Volume11,355 Change-3.00%
Mar-26-15 01:04PM  ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Financials
Mar-23-15 02:30PM  New Era Orthopaedics, LLC, to unveil new FDA-approved knee implants at the AAOS Annual Meeting - Booth 1357 - March 25 - 27, 2015 PR Newswire +6.35%
11:30AM  Micron Medical to Showcase New Brand, Contract Manufacturing Capabilities at World's Largest Meeting of Orthopaedic Surgeons and Allied Professions PR Newswire
Mar-20-15 07:53AM  ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition -6.11%
06:55AM  Arrhythmia Research Technology Reports 12.8% Net Sales Growth and 5.1 Point Margin Expansion in 2014 GlobeNewswire
Mar-02-15 01:30PM  Micron Products, Inc. Appoints Michael Collette as Vice President of Quality GlobeNewswire
Jan-23-15 04:32PM  ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 8-K/A, Change in Directors or Principal Officers, Regulation F
Jan-12-15 04:08PM  ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD
04:05PM  Arrhythmia Research Technology, Inc. Appoints Derek T. Welch as Chief Financial Officer GlobeNewswire
Dec-23-14 03:37PM  ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibi
12:18PM  Micron Products, Inc. Announces Exclusive Agreement With New Era Orthopaedics, LLC GlobeNewswire
Dec-04-14 06:50AM  Arrhythmia Research Tech (HRT) Upgraded From Sell to Hold at TheStreet
Nov-14-14 07:09PM  10-Q for Arrhythmia Research Technology, Inc. Company Spotlight
Nov-12-14 08:14AM  ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition
06:55AM  Arrhythmia Research Technology, Inc. Achieved 27.9% Revenue Growth and $0.05 Earnings Per Share for Third Quarter 2014 GlobeNewswire
Oct-30-14 01:30PM  Micron Products, Inc. Appoints Albert McGrath as Vice President of Operations GlobeNewswire
Aug-08-14 06:00AM  ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition EDGAR Online
Aug-07-14 04:05PM  Arrhythmia Research Technology, Inc. Reports 28.1% Revenue Growth; Delivered $0.09 in Earnings per Share for Second Quarter 2014 GlobeNewswire
Jul-01-14 06:00AM  ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement EDGAR Online
May-27-14 05:09PM  ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online
May-09-14 02:41PM  5 Stocks Ready for Breakouts at TheStreet +9.30%
08:51AM  ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 10-Q, Quarterly Report EDGAR Online
06:55AM  Arrhythmia Research Technology, Inc. Reports Earnings Per Share of $0.09 on 6.9% Increase in First Quarter 2014 Sales GlobeNewswire
Mar-27-14 01:04PM  ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Financials EDGAR Online Financials
Mar-21-14 04:18PM  ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial EDGAR Online
04:15PM  Arrhythmia Research Technology, Inc. Announces Fourth Quarter and 2013 Year End Results Marketwired
Mar-11-14 11:47AM  Needing Smarter, More Cost-Effective Production, Medical OEMs Turn to Contract Manufacturing PR Newswire -15.02%
Feb-19-14 02:25PM  Arrhythmia Research Technology, Inc. Announces Supply Agreement With Blue Belt Technologies, Inc. Marketwired
Feb-14-14 05:15PM  ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 8-K, Regulation FD Disclosure EDGAR Online
09:21AM  Arrhythmia Research Technology, Inc. Announces Date of Annual Meeting of Shareholders Marketwired
Jan-14-14 08:11AM  ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
Jan-10-14 06:00AM  ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 8-K/A, Submission of Matters to a Vote of Security Holders EDGAR Online
Dec-23-13 09:13AM  ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered EDGAR Online +12.06%
09:06AM  Arrhythmia Research Technology, Inc. Announces Closing of Private Placement Marketwired
Arrhythmia Research Technology, Inc. manufactures and sells components, devices, and equipment for medical, military, law enforcement, industrial, and automotive applications. It produces sells silver/silver chloride coated and conductive resin sensors used as component parts to manufacture integrated disposable electrophysiological sensors, which are used in the monitoring of electrical signals in various medical applications, as well as produces orthopedic implants. The company also licenses customizable proprietary signal-averaged electrocardiography software under Predictor brand that is used in research and clinical environments to diagnose the risk of certain heart arrhythmias. In addition, it performs custom thermoplastic injection molding, as well as provides design, engineering, and production services and management. The company operates in the United States, Canada, Europe, the Pacific Rim, and other countries. Arrhythmia Research Technology, Inc. was founded in 1981 and is based in Fitchburg, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Emma Salvatore JrPRESIDENT and CEOAug 19Sale7.208,60061,9572,027Aug 20 04:40 PM
Emma Salvatore JrPRESIDENT and CEOAug 18Sale7.224,40031,7900Aug 20 04:40 PM
Chambers Jason RussellDirectorAug 14Sale7.305,00036,500100,043Aug 14 02:34 PM